SignatureFD’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-159
| Closed | -$20.4K | – | 3394 |
|
|
2025
Q2 | $20.4K | Buy |
159
+6
| +4% | +$623 | ﹤0.01% | 2048 |
|
|
2025
Q1 | $13.5K | Sell |
153
-27
| -15% | -$2.63K | ﹤0.01% | 2246 |
|
|
2024
Q4 | $15.7K | Buy |
180
+11
| +7% | +$1.01K | ﹤0.01% | 2179 |
|
|
2024
Q3 | $15.6K | Sell |
169
-18
| -10% | -$1.79K | ﹤0.01% | 2161 |
|
|
2024
Q2 | $20.2K | Buy |
187
+38
| +26% | +$3.8K | ﹤0.01% | 1968 |
|
|
2024
Q1 | $14.1K | Hold |
149
| – | – | ﹤0.01% | 2174 |
|
|
2023
Q4 | $13.7K | Sell |
149
-136
| -48% | -$8.81K | ﹤0.01% | 2109 |
|
|
2023
Q3 | $14.3K | Sell |
285
-7
| -2% | -$374 | ﹤0.01% | 2019 |
|
|
2023
Q2 | $18.5K | Buy |
292
+123
| +73% | +$6.69K | ﹤0.01% | 1931 |
|
|
2023
Q1 | $7.6K | Buy |
169
+52
| +44% | +$2.34K | ﹤0.01% | 2328 |
|
|
2022
Q4 | $5.13K | Sell |
117
-85
| -42% | -$4.08K | ﹤0.01% | 2472 |
|
|
2022
Q3 | $13K | Sell |
202
-61
| -23% | -$3.92K | ﹤0.01% | 1937 |
|
|
2022
Q2 | $13K | Buy |
263
+124
| +89% | +$7.26K | ﹤0.01% | 1976 |
|
|
2022
Q1 | $9K | Buy |
139
+32
| +30% | +$2.3K | ﹤0.01% | 2186 |
|
|
2021
Q4 | $11K | Buy |
107
+17
| +19% | +$1.78K | ﹤0.01% | 2067 |
|
|
2021
Q3 | $9K | Buy |
90
+2
| +2% | +$186 | ﹤0.01% | 2102 |
|
|
2021
Q2 | $8K | Buy |
88
+1
| +1% | +$92 | ﹤0.01% | 2067 |
|
|
2021
Q1 | $8K | Buy |
87
+1
| +1% | +$100 | ﹤0.01% | 1931 |
|
|
2020
Q4 | $10K | Hold |
86
| – | – | ﹤0.01% | 1687 |
|
|
2020
Q3 | $8K | Buy |
86
+20
| +30% | +$1.54K | ﹤0.01% | 1704 |
|
|
2020
Q2 | $5K | Hold |
66
| – | – | ﹤0.01% | 1779 |
|
|
2020
Q1 | $4K | Buy |
+66
| New | +$4.25K | ﹤0.01% | 1722 |
|
Other funds holding BPMC
IA
HNB
SignatureFD's BPMC Position: Q3 2025 in Review
SignatureFD sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 159 shares — an estimated $20.4K sold.
SignatureFD first reported a position in BPMC in Q1 2020 and held it in 22 quarters. The position peaked at $20.4K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- SignatureFD reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- SignatureFD sold 159 Blueprint Medicines shares in Q3 2025, an estimated $20.4K.
- SignatureFD first reported a position in Blueprint Medicines in Q1 2020 and held it in 22 quarters.
- SignatureFD's Blueprint Medicines position peaked at $20.4K in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on SignatureFD's 13F filing for Q3 2025, filed 21 Oct 2025.